Literature DB >> 18167465

Laboratory assays in pediatric endocrinology: common aspects.

Jon Nakamoto1, John S Fuqua.   

Abstract

With a rapidly expanding armamentarium of tests, endocrinologists need the ability to critically assess a laboratory assay and to understand its application. There are numerous important issues to consider. Analytical validation ensures that an assay meets standards for sensitivity, specificity and reproducibility. Clinical validation allows the results of a test to be effectively applied to a given clinical situation. Antibody-based endocrine assays are typically either competitive or non-competitive. For competitive assays, an interference that decreases signal will lead to an apparent increase in the analyte concentration, while an interference that decreases signal in a non-competitive assay will cause an apparent decrease in the analyte concentration. Mass spectrometry is rapidly increasing in use and has its own promises and pitfalls. Numerous methods exist for determining reference intervals, each giving different results. Making endocrine diagnoses based on such intervals may be overly simplistic and collaboration between clinicians and the laboratory to establish clinical thresholds would be far more informative.

Mesh:

Substances:

Year:  2007        PMID: 18167465

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  4 in total

1.  Endocrine labomas.

Authors:  Deep Dutta; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2012-12

2.  UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development.

Authors:  S Faisal Ahmed; John C Achermann; Wiebke Arlt; Adam H Balen; Gerry Conway; Zoe L Edwards; Sue Elford; Ieuan A Hughes; Louise Izatt; Nils Krone; Harriet L Miles; Stuart O'Toole; Les Perry; Caroline Sanders; Margaret Simmonds; A Michael Wallace; Andrew Watt; Debbie Willis
Journal:  Clin Endocrinol (Oxf)       Date:  2011-07       Impact factor: 3.478

3.  Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency.

Authors:  Nélio Neves Veiga-Junior; Pedro Augusto Rodrigues Medaets; Reginaldo José Petroli; Flávia Leme Calais; Maricilda Palandi de Mello; Carla Cristina Telles de Sousa Castro; Guilherme Guaragna-Filho; Letícia Espósito Sewaybricker; Antonia Paula Marques-de-Faria; Andréa Trevas Maciel-Guerra; Gil Guerra-Junior
Journal:  Int J Endocrinol       Date:  2011-12-12       Impact factor: 3.257

4.  Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015).

Authors:  S Faisal Ahmed; John C Achermann; Wiebke Arlt; Adam Balen; Gerry Conway; Zoe Edwards; Sue Elford; Ieuan A Hughes; Louise Izatt; Nils Krone; Harriet Miles; Stuart O'Toole; Les Perry; Caroline Sanders; Margaret Simmonds; Andrew Watt; Debbie Willis
Journal:  Clin Endocrinol (Oxf)       Date:  2015-08-13       Impact factor: 3.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.